Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Complications of Diabetes Mellitus

moxifloxacin has been researched along with Complications of Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CH; Chou, HW; Lai, MS; Lee, JJ; Shau, WY; Wang, JL1
Joukhadar, C; Kovar, F; Lackner, E; Minar, E; Müller, M; Müller-Zellenberg, U; Stass, H1

Other Studies

2 other study(ies) available for moxifloxacin and Complications of Diabetes Mellitus

ArticleYear
Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cohort Studies; Diabetes Complications; Female; Fluoroquinolones; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Moxifloxacin; Odds Ratio; Propensity Score; Quinolines; Taiwan

2013
Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aza Compounds; Diabetes Complications; Diabetes Mellitus; Female; Fluoroquinolones; Humans; Male; Microdialysis; Middle Aged; Moxifloxacin; Quinolines; Soft Tissue Infections; Tissue Distribution

2003